“Patient-Reported Outcomes With Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body in the Phase 3 ARRECTOR Trial”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s525. https://doi.org/10.25251/skin.10.supp.525.